Dipeptidyl peptidase 4 inhibitors
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Dipeptidyl peptidase 4 inhibitors are oral antidiabetes agents that help control blood sugar levels in Type 2 diabetes patients. They inhibit the enzyme dipeptidyl peptidase 4 and regulate the levels of insulin the body produces after a meal. Dipeptidyl peptidase 4 inhibition results in increased activity of incretins, which inhibits glucagon release. This leads to increased insulin secretion, decreased gastric emptying and therefore decreased blood sugar levels.
Filter by:
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
|
|---|---|---|---|
| saxagliptin systemic (Pro, More...) |
9 reviews | 7.6 | |
| sitagliptin systemic (Pro, More...) |
30 reviews | 7.1 | |
| linagliptin systemic (Pro, More...) |
14 reviews | 4.8 | |
| alogliptin systemic (More...) |
0 reviews | 0.0 | |
See also
Medical conditions associated with dipeptidyl peptidase 4 inhibitors:
